Citation Impact
Citing Papers
The maternal interleukin-17a pathway in mice promotes autism-like phenotypes in offspring
2016 StandoutScience
Accelerating extinction risk from climate change
2015 StandoutScience
Risks of gastrointestinal bleeding during secondary prevention of vascular events with aspirin--analysis of gastrointestinal bleeding during the UK-TIA trial.
1995
INTREPAD
2019
The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation
2016
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
2009 Standout
Lansoprazole for the Prevention of Recurrences of Ulcer Complications from Long-Term Low-Dose Aspirin Use
2002 Standout
Efficacy of Esomeprazole (20 mg Once Daily) for Reducing the Risk of Gastroduodenal Ulcers Associated With Continuous Use of Low-Dose Aspirin
2008
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 Standout
Inflammation and cancer
2002 StandoutNature
Clopidogrel with or without Omeprazole in Coronary Artery Disease
2010 Standout
Reduced Risk of Upper Gastrointestinal Ulcer Complications With Celecoxib, A Novel Cox-2 Inhibitor
2000
Rheumatoid arthritis
2016 Standout
Recent considerations in nonsteroidal anti-inflammatory drug gastropathy
1998
Mechanism of Action of Anti-Inflammatory Drugs
1996
Rivaroxaban in Patients with a Recent Acute Coronary Syndrome
2011 Standout
Individual Nonsteroidal Antiinflammatory Drugs and Other Risk Factors for Upper Gastrointestinal Bleeding and Perforation
1997 Standout
Endometriosis
2009 Standout
Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis
2000 Standout
New Antithrombotic Drugs
2012
Nitrovasodilators, Low-Dose Aspirin, Other Nonsteroidal Antiinflammatory Drugs, and the Risk of Upper Gastrointestinal Bleeding
2000
Platelet-Active Drugs
1998
Protocol for Birmingham Atrial Fibrillation Treatment of the Aged study (BAFTA): a randomised controlled trial of warfarin versus aspirin for stroke prevention in the management of atrial fibrillation in an elderly primary care population [ISRCTN89345269]
2003
Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers
1997
Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention
2005 Standout
Anti-inflammatory and Upper Gastrointestinal Effects of Celecoxib in Rheumatoid Arthritis
1999
Cloning, Expression, and Up-regulation of Inducible Rat Prostaglandin E Synthase during Lipopolysaccharide-induced Pyresis and Adjuvant-induced Arthritis
2001
Omeprazole Compared with Misoprostol for Ulcers Associated with Nonsteroidal Antiinflammatory Drugs
1998
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison
1999
Platelet Activation and Atherothrombosis
2007 Standout
Clopidogrel with Aspirin in Acute Minor Stroke or Transient Ischemic Attack
2013 Standout
Antiplatelet Drugs
2012
Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial
2004 Standout
Gastrointestinal Toxicity With Celecoxib vs Nonsteroidal Anti-inflammatory Drugs for Osteoarthritis and Rheumatoid Arthritis
2000 Standout
Stroke
2008 Standout
Inflammatory Bowel Disease
2002 Standout
COX-2???Specific Inhibitors: Definition of a New Therapeutic Concept
2001
Effect of Pretreatment Antibiotic Resistance to Metronidazole and Clarithromycin on Outcome of Helicobacter pylori Therapy
2000
Relative Risk of Upper Gastrointestinal Complications among Users of Acetaminophen and Nonsteroidal Anti-Inflammatory Drugs
2001
Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database
2000
Antimicrobial-resistant bacteria in the community setting
2005
The safety profile, tolerability, and effective dose range of rofecoxib in the treatment of rheumatoid arthritis
1999
Adverse Upper Gastrointestinal Effects of Rofecoxib Compared With NSAIDs
1999
Nonsteroidal Anti-inflammatory Drugs and Upper Gastrointestinal Bleeding, Identifying High-Risk Groups by Excess Risk Estimates
1995
Inflammation and cancer: back to Virchow?
2001 Standout
Comparative Safety and Tolerability of Clopidogrel and Aspirin
1999
Gastrointestinal Toxicity of Nonsteroidal Antiinflammatory Drugs
1999 Standout
Trim and Fill: A Simple Funnel‐Plot–Based Method of Testing and Adjusting for Publication Bias in Meta‐Analysis
2000 Standout
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
2008 Standout
Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial
2007 Standout
Helicobacter pyloriInfection
2002 Standout
Aspirin Dose for the Prevention of Cardiovascular Disease
2007
A guideline for the treatment and prevention of NSAID-induced ulcers
1998
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review
2007 Standout
Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin
2001 Standout
Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis
2007 Standout
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 Standout
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration
2009 Standout
Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study
1998
Conflict of Interest in the Debate over Calcium-Channel Antagonists
1998 Standout
Variability in risk of gastrointestinal complications with individual non-steroidal anti-inflammatory drugs: results of a collaborative meta-analysis
1996
Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product
1996
A Randomized, Double-Blind, Crossover Comparative Endoscopy Study on the Gastroduodenal Tolerability of a Highly Specific Cyclooxygenase-2 Inhibitor, Flosulide, and Naproxen
1997
Immune involvement in schizophrenia and autism: Etiology, pathology and animal models
2008
Bias in meta-analysis detected by a simple, graphical test
1997 Standout
Platelet-Active Drugs
2001
Platelet-Active Drugs: The Relationships Among Dose, Effectiveness, and Side Effects
2004
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Gastrointestinal bleeding in high risk survivors of myocardial infarction: the VALIANT Trial
2009
Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes
2007 Standout
Non-steroidal anti-inflammatory drugs are associated with emergency admission to hospital for colitis due to inflammatory bowel disease.
1997
Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial
2006 Standout
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
2009 Standout
Association between aspirin and upper gastrointestinal complications: Systematic review of epidemiologic studies
2001
Gastroduodenal Tolerance of 75 mg Clopidogrel versus 325 mg Aspirin in Healthy Volunteers: A Gastroscopic Study
2000
Antagonism to calcium antagonists
1996
Nonsteroidal Anti-Inflammatory Drug Gastropathy
1996
Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology
2001 StandoutScience
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Role of Prostacyclin in the Cardiovascular Response to Thromboxane A 2
2002 StandoutScience
Reduced Risk of Colorectal Cancer among Long-Term Users of Aspirin and Nonaspirin Nonsteroidal Antiinflammatory Drugs
2001
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
2012 Standout
NSAIDs, Cox-2 inhibitors, and the gut
1995
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
2009 Standout
Protein Radicals in Enzyme Catalysis
1998 Standout
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
2009 Standout
Aspirin as an Adjunct to Screening for Prevention of Sporadic Colorectal Cancer: A Cost-Effectiveness Analysis
2001
Conducting Meta-Analyses inRwith themetaforPackage
2010 Standout
Works of J Weil being referenced
The Association between Exposure to COX-2 Inhibitors and Schizophrenia Deterioration. A Nested Case-Control Study
2007
Helicobacter pylori infection treated with a tripotassium dicitrato bismuthate and metronidazole combination
1990
Peptic ulcer bleeding: accessory risk factors and interactions with non-steroidal anti-inflammatory drugs
2000
Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States over a 10-year period: Alexander Project
2005
Prophylactic aspirin and risk of peptic ulcer bleeding
1995
Risks of bleeding peptic ulcer associated with individual non-steroidal anti-inflammatory drugs
1994
Reinfection or recrudescence after apparently successful eradication of <italic>Helicobacter pylori</italic> infection: implications for treatment of patients with duodenal ulcer disease
1993
Advantages and problems with pregnancy registries: observations and surprises throughout the life of the International Lamotrigine Pregnancy Registry
2014